Based on data from the past 90 days ending January 10, 2026, Xeris Biopharma Holdings's three largest insider shareholders are Director Paul R Edick (3.80Mn shares), Director John Patrick Jr Shannon (2.80Mn shares), Officer Kevin Mcculloch (1.69Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Paul R Edick | Nan | 3,801,494 | 31 Jan, 2024 |
| John Patrick Jr Shannon | Nan | 2,797,647 | 06 Jan, 2026 |
| Kevin Mcculloch | Nan | 1,685,426 | 09 Jan, 2026 |
| Steven Pieper | Nan | 1,417,561 | 03 Feb, 2025 |
| Beth Hecht | Nan | 1,308,103 | 05 Jan, 2026 |
| Steven Prestrelski | Chief Scientific Officer | 719,780 | 01 Feb, 2023 |
| John Johnson | 698,083 | 19 Dec, 2025 | |
| Kenneth Erland Johnson | Nan | 320,446 | 03 Feb, 2025 |
| Jeffrey W Sherman | 219,188 | 29 Aug, 2025 | |
| Garheng Kong | 214,144 | 04 Jun, 2025 | |
| Barbara-Jean Anne Bormann-Kennedy | 142,500 | 15 Dec, 2025 | |
| Marla Persky | 142,000 | 12 Sep, 2025 | |
| John P. Schmid | 138,359 | 05 Jun, 2024 | |
| Ricki Louise Fairley | 135,000 | 05 Jun, 2024 | |
| Dawn Halkuff | 115,000 | 13 Aug, 2025 | |
| James Aloysius Brady | 100,000 | 28 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Jan, 2026 | Kevin Mcculloch | Common Stock | D | 15,000 | $8.00 | 1,685,426 | D | S |
| 05 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 2,900 | $3.94 | 2,797,647 | D | M |
| 05 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 64,265 | $1.55 | 2,769,611 | D | M |
| 05 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 25,136 | $1.55 | 2,794,747 | D | M |
| 05 Jan, 2026 | John Patrick Jr Shannon | Common Stock | D | 24,907 | $7.08 | 2,705,346 | D | S |
| 02 Jan, 2026 | Beth Hecht | Common Stock | D | 16,667 | $7.43 | 1,308,103 | D | S |
| 19 Dec, 2025 | John Johnson | Common Stock | D | 135,400 | $7.22 | 698,083 | D | S |
| 19 Dec, 2025 | John Johnson | - | - | 698,083 | D | |||
| 12 Dec, 2025 | Barbara-Jean Anne Bormann-Kennedy | - | - | 142,500 | D | |||
| 12 Dec, 2025 | Barbara-Jean Anne Bormann-Kennedy | Common Stock | D | 15,000 | $7.09 | 142,500 | D | S |
| 01 Dec, 2025 | Beth Hecht | Common Stock | D | 16,667 | $7.01 | 1,320,176 | D | S |
| 14 Nov, 2025 | John Patrick Jr Shannon | Common Stock | A | 87,100 | $1.55 | 2,730,253 | D | M |
| 13 Nov, 2025 | John Patrick Jr Shannon | Common Stock | D | 23,242 | $7.46 | 2,643,153 | D | S |
| 13 Nov, 2025 | John Patrick Jr Shannon | Common Stock | A | 8,970 | $1.55 | 2,666,395 | D | M |
| 11 Nov, 2025 | Beth Hecht | Common Stock | D | 16,667 | $7.40 | 1,336,843 | D | S |
| 02 Oct, 2025 | Kevin Mcculloch | Common Stock | D | 733 | $8.31 | 1,700,426 | D | F |
| 11 Sep, 2025 | Marla Persky | Common Stock | D | 15,500 | $7.72 | 142,000 | D | S |
| 11 Sep, 2025 | Kevin Mcculloch | Common Stock | D | 2,000 | $0.00 | 0 | I | J |
| 11 Sep, 2025 | Kevin Mcculloch | - | - | 0 | I | |||
| 28 Aug, 2025 | Jeffrey W Sherman | Common Stock | D | 42,232 | $7.92 | 219,188 | D | S |